2276.HK
Shanghai Conant Optical Co., Ltd.

Healthcare · Medical Instruments & Supplies · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

1.64B USD

Market Cap

2.20B USD

Margin of Safety

-33.9%

Intrinsic / Market Ratio

0.75×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

1.33B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

1.87B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

1.72B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

1.64B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

1.64B USD

from the sum above

Market Cap

2.20B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.75×

the ratio the screener ranks by; Margin of Safety -33.9% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 1.33B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)970.16M USD
+②Net Cash Today160.18M USD
+③Growth Value204.01M USD
=Value1.33B USD

EPV of the Operations (NOPAT over WACC)

970.16M USD

Net cash today

+160.18M USD

Growth Value

+204.01M USD

Value

1.33B USD

①EPV (earnings power value)

970.16M USD

②Net Cash Today

160.18M USD

③Growth Value

204.01M USD

Market value

Market Cap2.20B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-64.8%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 1.87B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE1.13B USD
+②Equity at Year 15, Today747.88M USD
=Value1.87B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

1.13B USD

②Equity at Year 15, Today

747.88M USD

Market value

Market Cap2.20B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-17.4%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 1.72B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF1.06B USD
+②Invested Capital at Year 15, Today500.63M USD
+③Net Cash Today160.18M USD
=Value1.72B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

1.06B USD

②Invested Capital at Year 15, Today

500.63M USD

③Net Cash Today

160.18M USD

Market value

Market Cap2.20B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-27.9%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 6.47%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.34×Market Risk Premium 6.00%= 6.56%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 11.50M USDPretax Income 91.30M USD= 12.60%

The tax the interest saves.

Interest Expense =EBIT 92.18M USD−Pretax Income 91.30M USD= 882.52K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 882.52K USDTotal Debt 42.78M USD×(1 − Tax Rate for WACC 12.60%)= 1.80%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 42.78M USDMarket Cap + Total Debt 2.20B USD + 42.78M USD= 1.91%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 98.09%×Cost of Equity 6.56%+Debt Weight 1.91%×Cost of Debt 1.80%= 6.47%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2025-12-31.

Total Assets 507.22M USD − Total Liabilities 114.72M USD = Book Value Today 392.50M USD

Total Debt 42.78M USD − Cash and Short-Term Investments 202.96M USD = Net Debt Today -160.18M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 19.0%at most 5%does not pass465,193,980 / 426,600,000
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets-0.6%at least -10.0%passes(76.78M USD − 79.80M USD) ÷ 507.22M USD
Price to bookMarket Cap ÷ Book Value Today5.60×at most 3×does not pass2.20B USD ÷ 392.50M USD
Operating marginOperating Income ÷ Revenue27.0%above 10.0%passes84.56M USD ÷ 312.77M USD
Revenue growthRevenue ÷ Revenue a Year Before − 110.7%above 10.0%passes312.77M USD / 282.65M USD
Net cash(Cash − Total Debt) ÷ Market Cap2.2%above -30%passes(90.14M USD − 42.78M USD) ÷ 2.20B USD
Operating efficiencyOperating Income ÷ Gross Profit64.4%above 25.0%passes84.56M USD ÷ 131.27M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

35.68 HKD

Enterprise value

15.60B HKD

the provider's own figure

EV / EBITDA

20.83×

Price / book

3.83×

the provider's book

Price / earnings

24.58×

Return on equity

18.4%

the provider's figure, not this page's

Profit margin

25.8%

Revenue growth

7.6%

Analyst target, mean

60.22 HKD

Analysts

7

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

224.45M247.84M282.65M312.77M

Gross profit

77.32M92.70M109.06M131.27M

Operating income

45.71M54.41M66.92M84.56M

EBITDA

operating income before depreciation and amortisation

51.03M65.60M79.83M104.27M

Pretax income

40.47M55.35M68.22M91.30M

Net income

35.73M46.06M58.74M79.80M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

40.52M47.40M60.10M75.29M

R&D

————
Balance sheet, year end

Total assets

257.13M279.48M327.64M507.22M

Total liabilities

92.44M83.02M110.17M114.72M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

164.69M196.47M217.47M392.50M

Total debt

51.05M30.28M43.55M42.78M

Cash and equivalents

48.25M46.55M68.45M90.14M

Net PP&E

fixed assets after depreciation

59.95M67.85M87.68M121.65M

Working capital

current assets less current liabilities

121.02M138.45M121.63M263.45M
Cash flow

Operating cash flow

26.61M67.70M65.54M76.78M

Capital expenditure

paid out, so below zero

-17.18M-18.62M-30.89M-42.17M

Depreciation and amortisation

6.86M8.33M10.21M12.09M

Free cash flow

operating cash flow plus capital expenditure

9.43M49.08M34.65M34.61M